The 36-month beta value for DH is at 1.60. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for DH is 38.09M, and currently, shorts hold a 10.13% of that float. The average trading volume for DH on June 13, 2025 was 895.63K shares.
DH) stock’s latest price update
Definitive Healthcare Corp (NASDAQ: DH) has seen a decline in its stock price by -3.20 in relation to its previous close of 3.75. However, the company has experienced a 1.97% gain in its stock price over the last five trading sessions. globenewswire.com reported 2025-06-03 that FRAMINGHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare’s Board of Directors granted an inducement award.
DH’s Market Performance
DH’s stock has risen by 1.97% in the past week, with a monthly rise of 0.83% and a quarterly rise of 40.15%. The volatility ratio for the week is 2.51% while the volatility levels for the last 30 days are 3.31% for Definitive Healthcare Corp The simple moving average for the past 20 days is 6.78% for DH’s stock, with a -7.86% simple moving average for the past 200 days.
Analysts’ Opinion of DH
Barclays, on the other hand, stated in their research note that they expect to see DH reach a price target of $4. The rating they have provided for DH stocks is “Underweight” according to the report published on January 13th, 2025.
Stephens gave a rating of “Equal-Weight” to DH, setting the target price at $5 in the report published on December 20th of the previous year.
DH Trading at 20.55% from the 50-Day Moving Average
After a stumble in the market that brought DH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -42.06% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DH starting from Moschella William, who sale 45,000 shares at the price of $4.70 back on Dec 03 ’24. After this action, Moschella William now owns 433,830 shares of Definitive Healthcare Corp, valued at $211,500 using the latest closing price.
Moschella William, the Officer of Definitive Healthcare Corp, proposed sale 45,000 shares at $4.65 during a trade that took place back on Dec 03 ’24, which means that Moschella William is holding shares at $209,250 based on the most recent closing price.
Stock Fundamentals for DH
Current profitability levels for the company are sitting at:
- -2.07 for the present operating margin
- 0.73 for the gross margin
The net margin for Definitive Healthcare Corp stands at -2.06. The total capital return value is set at -0.79. Equity return is now at value -86.36, with -39.01 for asset returns.
Based on Definitive Healthcare Corp (DH), the company’s capital structure generated 0.36 points at debt to capital in total, while cash flow to debt ratio is standing at 0.37. The debt to equity ratio resting at 0.56. The interest coverage ratio of the stock is -38.12.
Currently, EBITDA for the company is -567.24 million with net debt to EBITDA at -0.13. When we switch over and look at the enterprise to sales, we see a ratio of 1.87. The receivables turnover for the company is 5.78for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.66.
Conclusion
In conclusion, Definitive Healthcare Corp (DH) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
